4 ways to promote healthy hearing to reduce the risk of cognitive decline
By
Annette Mazevski, Au.D., Ph.D.
Oct 08, 2020
As owners and operators of senior living communities, here’s how you and your employees can spot hearing loss, get residents the help they need, and create a better hearing environment.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
Financial altruism may indicate cognitive decline in seniors
Jun 22, 2022
“Trouble handling money is thought to be one of the early signs of Alzheimer’s disease, and this finding supports that notion.”
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Racial, ethnic disparities explored in subjective cognitive decline
Jul 08, 2021
More Black and Hispanic adults than white adults report subjective cognitive decline at age 45 to 54 years.
Promising Alzheimer’s treatment options lead to expanded PET scan recommendations
By
Aaron Dorman
Jul 24, 2023
CMS is now recommending expanding coverage for PET scans by lifting the current single-test limit.
Yoga, meditation improve brain fitness: study
By
Lois A. Bowers
May 11, 2016
Yoga and meditation can offer a simple, safe and low-cost solution for improving brain fitness, according to new research. Combined, they were found to be even more effective than what many consider to...
Lumosity to pay $2 million to settle deceptive advertising charges
By
Lois A. Bowers
Jan 07, 2016
Lumosity has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers with unfounded claims that its “brain games” can reduce or delay cognitive impairment...